The Effects of Laparoscopic Sleeve Gastrectomy on Obesity-Related Hypertriglyceridemia-Induced Acute Pancreatitis
- 106 Downloads
Hypertriglyceridemia-induced acute pancreatitis (HTG-AP) is a significant clinical problem and is characterized by high recurrence rate compared with non-HTG-AP. The objective of this study was to investigate the effects of laparoscopic sleeve gastrectomy (LSG) on obesity-related HTG-AP.
Twenty-nine patients with obesity-related HTG-AP were admitted to our hospital and treated with the conventional therapy or LSG surgery according to the wishes of patients. Clinical data and the recurrence rate of AP were collected at baseline and at four different time points (3, 6, 9, and 12 months) after the treatments for all patients.
Of the 29 patients, 28 patients (19 patients with conventional therapy and 9 patients with LSG surgery) completed the 12-month follow-up. Clinical data and the severity scores of AP were comparable at baseline when the patients were admitted to the intensive care unit. The LSG group experienced a large weight loss (percent total weight loss, 26.87 ± 1.44%; percent excess weight loss, 79.56 ± 1.37%) and triglyceride reduction (from 15.77 ± 1.02 to 1.36 ± 0.09 mmol/L), and no recurrence was observed at 12 months after the surgery. In the conventional treatment group, however, body weight was not changed although triglyceride was significantly decreased (from 17.34 ± 1.29 to 8.25 ± 1.12 mmol/L), and more importantly, 47.4% of the patients had at least one recurrence of AP in 12 months after the treatment.
LSG might be an effective way to cure obesity-related HTG-induced AP since it prevents the recurrence of this disease. Further randomized studies will be needed to standardize this way of treatment.
KeywordsLaparoscopic sleeve gastrectomy Acute pancreatitis Obesity Hypertriglyceridemia
This research was supported by the National Natural Science Foundation of China (81500396), Foundation of Sichuan Educational Committee (18CZ0023, 17ZA0172), Foundation of Sichuan Health and Family Planning Commission (18PJ496), and Foundation of North Sichuan Medical College (CBY15-QD001).
Compliance with Ethical Standards
Conflict of Interest
The authors declare that they have no conflict of interest.
All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and/or national research committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards.
Informed consent was obtained from all individual participants included in the study.
- 13.Chinese Society for Metabolic and Bariatric Surgery. The 2014 guidelines for the surgical treatment of obesity and type 2 diabetes in China. Chin J Prac Surg. 2014;34(11):1005–10.Google Scholar
- 14.The Joint Committee on Prevention and Control of Abnormal Blood Lipid Levels in Chinese Adults. The 2016 guidelines for prevention and treatment of dyslipidemia in Chinese adults (revised edition in 2016). Chin Circul J. 2016;31(10):937–53.Google Scholar